Compugen (CGEN)
Builds cancer immunotherapies from computationally predicted drug targets.
$2.65
Pre-market+0.03 (+1.00%)
At close$2.63(+1.35%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions81 holders · as of Mar 31, 2026 | 15.02% | 14.21M ADS | |
| Insiders12 holders · as of Jul 30, 2026 | 0.43% | 406.4K ADS | |
| Strategic holders1 holder · as of Nov 19, 2021 | 5.03% | 4.76M ADS | |
| Otherremainder | 79.52% | 75.18M ADS |
94.55M ADS as of Sep 3, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Institutions13F, as of Mar 31, 2026
81 holders · 14.21M shares · 13 new positions · 32 increased · 15 reduced · 7 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Silverarc Capital Management, LLC | 3.32M | 3.51% | −164.0K | May 14, 2026 |
| Renaissance Technologies LLC | 1.63M | 1.73% | +176.1K | May 14, 2026 |
| Morgan Stanley | 1.05M | 1.11% | +43.5K | May 15, 2026 |
| Ark Investment Management LLC | 1.05M | 1.11% | +1.05Mnew | May 12, 2026 |
| Macquarie Management Holdings, Inc. | 1.02M | 1.08% | 0 | May 15, 2026 |
| Taylor Frigon Capital Management LLC | 848.0K | 0.90% | −21.2K | Apr 29, 2026 |
| Northern Trust Corp | 650.9K | 0.69% | −8.0K | May 14, 2026 |
| Two Sigma Investments, LP | 521.6K | 0.55% | +217.6K | May 15, 2026 |
Ownership statements13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Insider tradesForm 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jul 9, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 1,875 | $2.50 | 29,375 |
| Apr 24, 2026 | Eran Ophirdirector, officer: President and CEO | Sale | 5,000 | $3.20 | 11,375 |
| Apr 24, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 2,000 | $3.20 | 29,375 |
| Apr 14, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 2,000 | $2.80 | 29,375 |
| Apr 14, 2026 | Eran Ophirdirector, officer: President and CEO | Sale | 5,000 | $2.90 | 11,375 |
| Apr 10, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 3,125 | $2.56 | 29,375 |
| Apr 7, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 2,500 | $2.30 | 29,375 |
| Apr 8, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 5,375 | $2.42 | 29,375 |
| Apr 1, 2026 | Eran Ophirdirector, officer: President and CEO | Sale | 5,625 | $2.21 | 11,375 |
| Apr 1, 2026 | Zurit Levineofficer: SVP, Business Development | Sale | 3,500 | $2.20 | 29,375 |
CongressHouse and Senate disclosures
Not reported.
